Nontremor

Nontremor parkinsonism (NTP) is a neurological disorder characterized by the presence of Parkinsonian symptoms, such as bradykinesia, rigidity, and postural instability, in the absence of tremor. It is a heterogeneous syndrome, meaning it can have various causes and presentations. NTP is often classified into two main types: primary and secondary.

Primary NTP is idiopathic, meaning its cause is unknown. It typically presents in the later stages of life, often after the age of 60. The symptoms may progress slowly over time, and the course of the disease can vary greatly among individuals.

Secondary NTP occurs as a result of other neurological conditions or medications. Common causes include:

1. Metabolic disorders: such as Wilson disease, porphyria, or mitochondrial disorders.

2. Infections: like HIV or syphilis.

3. Toxins: such as manganese or carbon monoxide poisoning.

4. Medications: certain drugs can cause Parkinsonian symptoms, including anticholinergics, antipsychotics, and some antidepressants.

5. Structural brain lesions: such as those caused by stroke, brain tumors, or multiple sclerosis.

The diagnosis of NTP is typically based on clinical examination and the absence of tremor. Imaging studies, such as MRI or PET scans, may be used to rule out other causes of Parkinsonian symptoms. Treatment of NTP depends on its underlying cause. If the cause is reversible, such as a medication-induced NTP, discontinuing the offending drug may be sufficient. If the cause is progressive or unknown, symptomatic treatment with levodopa or other dopaminergic medications may be considered. In some cases, deep brain stimulation may be an option.